Agenda
9:00 AM — 10:30 AM
#3 Action Learning for Six Sigma Analytical Tools Using Real Case Studies9:00 AM — 10:30 AM
#4 Coaching as a Diverse Communication Tool Across Functions and Areas9:00 AM — 10:30 AM
#5 The Basics of “Investigator Initiated Trial (IIT)” Regulation9:20 AM — 12:30 PM
Student Session11:00 AM — 12:30 PM
#10 HTA 2016? What are the challenges for Japan?11:00 AM — 12:30 PM
#6 Prediction for Human Pharmacokinetics and Safety Using Systems Pharmacology11:00 AM — 12:30 PM
#8 An Introduction to Adaptive Designs2:20 PM — 3:10 PM
Keynote Speech 13:10 PM — 4:00 PM
Keynote Speech 24:30 PM — 5:45 PM
Special Session: Opening Plenary9:00 AM — 10:30 AM
[V3-S1] The Dawn of Advanced Regulatory Review and Consultation9:00 AM — 10:30 AM
[V6-S1] Made in Academia: Seed Development Initiatives11:00 AM — 12:30 PM
[V6-S2] ARO Activities to Facilitate Late-Phase Clinical Trials in Asia2:00 PM — 3:30 PM
[V1-S3] Global Contribution for Clinical Development from Japan2:00 PM — 3:30 PM
[V3-S3] Lessons Learned of Adaptive Design from Case Example2:00 PM — 3:30 PM
[V6-S3] Management of COI in Clinical Trials and Future Perspective5:45 PM — 7:00 PM
Let’s Chat! – Presented by DIA Community9:00 AM — 10:30 AM
[V2-S5] Is the Risk Management Plan Really Effective? Part I9:00 AM — 10:30 AM
[V3-S5] Multi-Regional Clinical Trials: Where Should it Be Headed?9:00 AM — 10:30 AM
[V6-S5] Genomic Sampling Over Generations11:00 AM — 12:30 PM
[V2-S6] Is the Risk Management Plan Really Effective? Part II11:00 AM — 12:30 PM
[V3-S6] Beyond Japan: From Asian Studies to Global Studies2:50 PM — 3:00 PM
3:30 PM — 6:25 PM
PMDA Town Hall3:30 PM — 5:00 PM
Round Table: What are Expectations for “Adaptive Licensing"?6:25 PM — 6:30 PM
Closing RemarksHave an account?